Partnering

Partner with Us

ImmunoScape offers partnering opportunities centered on our transformative Seed-and-Boost approach. The flexibility of our platform technology enables the development of superior T cell therapies—independent of target, patient background, or cell modality.

Our booster molecules are designed to enhance the efficacy of existing CAR-T and TCR-T cell therapies, offering a powerful way to improve patient outcomes. We welcome partnerships with therapeutic companies to co-develop impactful booster molecules based on our clinical-stage assets.

Together, we can deliver next-generation T cell therapies to address the high unmet needs of patients with cancer.

Please contact us to explore innovative partnering models and value creation opportunities.